Dr. Dylan Greeney, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,273 | 292 | 97.3% |
| Education | $171.99 | 2 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,723 | 94 | $0 (2024) |
| Lilly USA, LLC | $747.54 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $547.22 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $490.07 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $448.56 | 19 | $0 (2024) |
| Amgen Inc. | $371.29 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $328.22 | 13 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $313.21 | 18 | $0 (2024) |
| GENZYME CORPORATION | $222.83 | 11 | $0 (2024) |
| Celgene Corporation | $215.34 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,805 | 101 | ABBVIE INC. ($488.81) |
| 2023 | $1,808 | 86 | ABBVIE INC. ($501.33) |
| 2022 | $1,292 | 73 | ABBVIE INC. ($415.00) |
| 2021 | $582.31 | 22 | VYNE Pharmaceuticals Inc. ($134.43) |
| 2020 | $110.47 | 1 | AbbVie Inc. ($110.47) |
| 2019 | $323.39 | 6 | Lilly USA, LLC ($121.86) |
| 2018 | $523.66 | 5 | Lilly USA, LLC ($291.72) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.51 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Immunology | ||||||
| 12/08/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $30.49 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: ACNE | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.61 | General |
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.99 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Immunology | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,563 | 3,052 | $612,446 | $76,031 |
| 2022 | 13 | 1,280 | 2,255 | $491,195 | $82,753 |
| 2021 | 7 | 183 | 263 | $59,390 | $12,833 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 279 | 383 | $65,110 | $16,290 | 25.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 285 | 391 | $105,570 | $12,306 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 180 | $44,640 | $12,068 | 27.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 47 | 55 | $43,725 | $6,722 | 15.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 89 | 89 | $22,161 | $5,103 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $20,295 | $4,244 | 20.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 71 | 74 | $22,940 | $3,319 | 14.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 166 | 204 | $103,428 | $3,094 | 3.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 40 | $18,440 | $2,394 | 13.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 14 | 15 | $11,115 | $2,133 | 19.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 228 | 1,357 | $66,493 | $1,838 | 2.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 29 | $18,821 | $1,818 | 9.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 24 | $13,200 | $1,459 | 11.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 68 | 106 | $26,394 | $1,336 | 5.1% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $5,544 | $972.44 | 17.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 37 | 39 | $24,570 | $934.20 | 3.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 230 | $39,100 | $13,445 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 152 | 152 | $37,848 | $10,379 | 27.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 183 | 216 | $109,512 | $10,355 | 9.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 201 | 286 | $77,220 | $9,827 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 89 | $22,072 | $7,376 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $27,675 | $6,717 | 24.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 30 | 30 | $23,850 | $5,680 | 23.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 84 | 126 | $31,374 | $3,981 | 12.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 54 | 56 | $17,360 | $3,697 | 21.3% |
About Dr. Dylan Greeney, MD
Dr. Dylan Greeney, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2017. The National Provider Identifier (NPI) number assigned to this provider is 1033639190.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dylan Greeney, MD has received a total of $6,445 in payments from pharmaceutical and medical device companies, with $1,805 received in 2024. These payments were reported across 294 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,273).
As a Medicare-enrolled provider, Greeney has provided services to 3,026 Medicare beneficiaries, totaling 5,570 services with total Medicare billing of $171,617. Data is available for 3 years (2021–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location Evansville, IN
- Active Since 06/20/2017
- Last Updated 09/14/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1033639190
Products in Payments
- SKYRIZI (Biological) $797.03
- TALTZ (Drug) $683.17
- Otezla (Drug) $586.63
- TREMFYA (Drug) $490.07
- Sotyktu (Drug) $431.43
- DUPIXENT (Biological) $429.53
- COSENTYX (Drug) $321.90
- RINVOQ (Biological) $282.04
- HUMIRA (Biological) $223.74
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $210.54
- ILUMYA (Biological) $156.96
- OPZELURA (Drug) $154.63
- AMZEEQ (Drug) $134.43
- ADBRY (Biological) $124.77
- DUPIXENT DUPILUMAB INJECTION (Biological) $121.52
- COSENTYX (Biological) $118.77
- Humira (Biological) $96.61
- JUBLIA (Drug) $91.98
- Winlevi (Drug) $91.62
- Ilumya (Biological) $64.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Evansville
Joseph Adongay, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $14,409
Leonid Drozhinin
Student in an Organized Health Care Education/Training Program — Payments: $12,226
Dr. Adam Becker, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,824
Elizabeth Luckett, P.a, P.A
Student in an Organized Health Care Education/Training Program — Payments: $4,988
Kyle Lemond, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,458
Ian Stamps, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2,784